Medicalsystem Biotechnology Co., Ltd (SHE:300439)
China · Delayed Price · Currency is CNY 10.26
+0.77 (8.11%)
Nov 2, 2026, 3:04 PM CST
SHE:300439 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,678 | 1,539 | 1,742 | 1,886 | 2,489 | 2,252 |
Revenue Growth | 14.04% | -11.67% | -7.61% | -24.23% | 10.55% | -2.19% |
Gross Profit Gross Profit Growth | 564.79 | 545.94 | 769.7 | 825.44 | 937.49 | 903.98 |
Operating Income Operating Income Growth | 69.77 | 5.51 | 240.63 | 230.97 | 236.63 | 238.6 |
Net Income Net Income Growth | 100.51 | 63.2 | 258 | 256.55 | 198.53 | 179.49 |
Earnings Per Share EPS Growth | 0.25 | 0.16 | 0.67 | 0.67 | 0.52 | 0.48 |
EPS Growth | 4.07% | -76.12% | 0% | 28.85% | 8.33% | -44.81% |
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
China China Growth | 1,504 | 1,727 | 1,874 | 2,473 | 2,238 |
Foreign Foreign Growth | 34.78 | 15.11 | 12.14 | 15.85 | 13.13 |
Total Total Growth | 1,539 | 1,742 | 1,886 | 2,489 | 2,252 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1,012 | 977.37 | 899.84 | 964.88 | 886.58 | 767.01 |
Total Debt Total Debt Growth | 91.88 | 59.22 | 82.92 | 93.17 | 331.64 | 481.87 |
Net Cash (Debt) Net Cash Growth | 920.52 | 918.15 | 816.92 | 871.71 | 554.94 | 285.14 |
Net Cash Growth | 8.12% | 12.39% | -6.29% | 57.08% | 94.62% | - |
Net Cash Per Share Net Cash Per Share Growth | 2.33 | 2.32 | 2.12 | 2.28 | 1.45 | 0.76 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 172 | 266.61 | 397.81 | 633.53 | 564.67 | 515.48 |
Capital Expenditures CapEx Growth | -152.67 | -191.41 | -420.54 | -280.37 | -303.13 | -201.82 |
Free Cash Flow Free Cash Flow Growth | 19.32 | 75.21 | -22.73 | 353.16 | 261.53 | 313.67 |
Free Cash Flow Growth | -83.30% | - | - | 35.04% | -16.62% | -40.66% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Gross Margin | 33.66% | 35.47% | 44.17% | 43.77% | 37.66% | 40.15% |
Operating Margin | 4.16% | 0.36% | 13.81% | 12.25% | 9.51% | 10.60% |
Pretax Margin | 6.06% | 2.99% | 16.21% | 15.68% | 8.97% | 9.69% |
Profit Margin | 5.99% | 4.11% | 14.81% | 13.60% | 7.98% | 7.97% |
FCF Margin | 1.15% | 4.89% | -1.30% | 18.73% | 10.51% | 13.93% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.033 | 0.033 | 0.135 | 0.134 | 0.105 | 0.095 |
Dividend Per Share Growth | -75.53% | -75.56% | 0.75% | 27.62% | 10.53% | -39.38% |
Dividend Yield | 0.32% | 0.34% | 1.29% | 1.15% | 0.90% | 0.45% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
PE Ratio | 40.33 | 59.90 | 15.55 | 17.33 | 22.57 | 45.47 |
Forward PE | - | 17.42 | 17.42 | 17.42 | 17.42 | 17.42 |
P/FCF Ratio | 188.74 | 50.34 | - | 12.59 | 17.13 | 26.02 |
PS Ratio | 2.17 | 2.46 | 2.30 | 2.36 | 1.80 | 3.63 |